Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HDAC Inhibitor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03198559
What this trial is testing

Combination Latency Reversal With High Dose Disulfiram Plus Vorinostat in HIV-infected Individuals on ART

Who this might be right for
HIV Infections
University of Melbourne 5
Early research (Phase 1)Study completedNCT02922946
What this trial is testing

Study to Determine the Effect of the Timing of a Meal on the Pharmacokinetics of Entinostat

Who this might be right for
VolunteersHealthy VolunteersHuman Volunteers+1 more
Syndax Pharmaceuticals 47
Testing effectiveness (Phase 2)Looking for participantsNCT07226141
What this trial is testing

Valproate for the Treatment of Residual Amblyopia

Who this might be right for
AmblyopiaAmblyopia UnilateralAmblyopia, Anisometropic+1 more
Boston Children's Hospital 28
Testing effectiveness (Phase 2)Study completedNCT01693601
What this trial is testing

Panobinostat and Ruxolitinib In MyElofibrosis (PRIME Trial)

Who this might be right for
Myelofibrosis
John Mascarenhas 15
Large-scale testing (Phase 3)UnknownNCT03553238
What this trial is testing

Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL

Who this might be right for
Leukemia, AcuteLeukemia, T CellLeukemia, Lymphoblastic
Nanfang Hospital, Southern Medical University 70
Early research (Phase 1)Ended earlyNCT04315233
What this trial is testing

Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics

Who this might be right for
Metastatic Breast CancerRecurrent Ovarian Carcinoma
University of Utah 12
Testing effectiveness (Phase 2)Study completedNCT00724984
What this trial is testing

Study of the Safety and Tolerability of PCI-24781 in Patients With Lymphoma

Who this might be right for
LymphomaHodgkin DiseaseLymphoma, Non-Hodgkin
Pharmacyclics LLC. 55
Early research (Phase 1)Study completedNCT01023737
What this trial is testing

Hydroxychloroquine + Vorinostat in Advanced Solid Tumors

Who this might be right for
Malignant Solid Tumour
The University of Texas Health Science Center at San Antonio 72
Early research (Phase 1)Study completedNCT03192111
What this trial is testing

Evaluate the Pharmacokinetics of Entinostat in Adult Subjects With Normal and Impaired Renal Function

Who this might be right for
Renal ImpairmentHealthy Volunteer
Syndax Pharmaceuticals 40
Large-scale testing (Phase 3)UnknownNCT03564704
What this trial is testing

Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL

Who this might be right for
LeukemiaLeukemia, AcuteAdult Lymphoblastic Lymphoma+5 more
Nanfang Hospital, Southern Medical University 80
Testing effectiveness (Phase 2)UnknownNCT04831710
What this trial is testing

Sintilimab in Combination With Chidamide in Refractory and Relapsed AITL

Who this might be right for
Angioimmunoblastic T-cell Lymphoma
Sun Yat-sen University 83
Early research (Phase 1)Ended earlyNCT01159301
What this trial is testing

Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia

Who this might be right for
Adult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+16 more
National Cancer Institute (NCI) 44
Testing effectiveness (Phase 2)Study completedNCT01486277
What this trial is testing

The Histone Deacetylase Inhibitor (HDACi) Quisinostat (JNJ-26481585) in Patients With Previously Treated Stage Ib-IVa Cutaneous T-cell Lymphoma

Who this might be right for
Lymphoma, T-Cell, Cutaneous
Janssen Research & Development, LLC 26
Early research (Phase 1)Study completedNCT02780804
What this trial is testing

Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Brain Stem NeoplasmPineal Region NeoplasmRecurrent Lymphoma+7 more
National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)Ended earlyNCT00496431
What this trial is testing

PhII Study of an HDAC Inhibitor in Very High-risk Relapsed/Refractory Hodgkin's Lymphoma Patients

Who this might be right for
Hodgkin's Lymphoma
Italfarmaco 19
Early research (Phase 1)Study completedNCT01132573
What this trial is testing

Entinostat and Clofarabine in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Poor-Risk Acute Lymphoblastic Leukemia or Bilineage/Biphenotypic Leukemia

Who this might be right for
Acute Leukemias of Ambiguous LineagePhiladelphia Chromosome Negative Adult Precursor Acute Lymphoblastic LeukemiaRecurrent Adult Acute Lymphoblastic Leukemia+1 more
National Cancer Institute (NCI) 27
Testing effectiveness (Phase 2)Ended earlyNCT01528501
What this trial is testing

Histone Deacetylases - Gastric Cancer (HDAC-GaCa-2008)

Who this might be right for
Metastatic Gastric Cancer
Technical University of Munich 28
Early research (Phase 1)Study completedNCT02936752
What this trial is testing

Testing the Safety and Efficacy of the Combination of the Antibody Pembrolizumab and Entinostat in Patients With Myelodysplastic Syndrome Who Are Not Responding to Hypomethylating Agents

Who this might be right for
Myelodysplastic Syndrome
National Cancer Institute (NCI) 28
Early research (Phase 1)UnknownNCT01159418
What this trial is testing

LBH589 Oral in Combination With Carboplatin and Paclitaxel in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Southern Europe New Drug Organization 36
Testing effectiveness (Phase 2)Ended earlyNCT00666497
What this trial is testing

Phase 2 Study of Azacitidine (Vidaza) vs MGCD0103 vs Combination in Elderly Subjects With Newly Diagnosed Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)
Mirati Therapeutics Inc. 6
Next Page